On Friday, Moderna’s mCombriax—a combined vaccine for both the flu and COVID—was recommended for authorization by European regulators, which opens the door for the vaccine’s approval in the European ...
For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...
The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA3.60%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results